药明生物:2024年新增151个项目,预计2025年收入加速增长

美港电讯
13 Jan

【药明生物:2024年新增151个项目,预计2025年收入加速增长】金十数据1月13日讯,药明生物今日发布公告,公布了最新业务进展,公司2024年新增151个项目,总项目数量已达到817个。其中包括66个临床III期项目以及21个非新冠CMO(商业化生产)项目。公司预计,2025年将有24个PPQ(工艺性能确认)项目推进,并且爱尔兰生产设施预计将按计划于2025年实现盈利。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10